title: Modulating mTOR in aging and health.
abstract: The physiological responses to nutrient availability play a central role in aging and disease. Genetic and pharmacological studies have identified highly conserved cellular signaling pathways that influence aging by regulating the interface between nutrient and hormone cues and cellular growth and maintenance. Among these pathways, the mechanistic target of rapamycin (mTOR) has been most reproducibly shown to modulate aging in evolutionarily diverse organisms as reduction in mTOR activity extends life span from yeast to rodents. mTOR has been shown to play a role in a broad range of diseases, and is of particular interest to human health and aging due to the availability of clinically approved pharmacological agents targeting the mTOR complexes and other components of the mTOR signaling network. Characterizing the role of mTOR in aging and health promises to provide new avenues for intervention in human aging and disease through modulation of this signaling pathway.
authors.affiliation: Department of Pathology, University of Washington, Seattle, Wash., USA.
authors.forename: Simon C
authors.initials: SC
authors.lastname: Johnson
authors.forename: Maya
authors.initials: M
authors.lastname: Sangesland
authors.forename: Matt
authors.initials: M
authors.lastname: Kaeberlein
authors.forename: Peter S
authors.initials: PS
authors.lastname: Rabinovitch
mesh_terms: D000375:Aging / Q000502:physiology*; D000818:Animals; D006304:Health Status; D006801:Humans; D015398:Signal Transduction / Q000502:physiology; D058570:TOR Serine-Threonine Kinases / Q000187:drug effects / Q000378:metabolism*
chemical_list: C546842:MTOR protein, human; D058570:TOR Serine-Threonine Kinases